Replies to post #346992 on NorthWest Biotherapeutics Inc (NWBO)

[branster]

Atlnsder, great response, thanks for the insight!

[marzan]

And I guess Oncovir is still a private one. I think Oncovir's Poly ICLC cannot act like a drug or therapy independently standing alone as a drug. It is a supplement to enhance immunotherpy activities, imo. LL at UAB said with these PICLC+Keytruda+ATL-DC combo, she effectively KILLS the cancer. I agree LP and Frazier are cutting some mega deal behind the curtains, but I think Bristol wants us too; don't know about others like Roche, but looks like a Bidding War has already started, and so the delayed 10Q and TLD etc etc, imo.